Clinical Trial Update: Phase 3, Randomized, Placebo-Controlled, Double-Blinded Trial of the Combined Lysis of Thrombus With Ultrasound and Systemic Tissue Plasminogen Activator (tPA) for Emergent Revascularization in Acute Ischemic Stroke [Phase 3]

View source ↗

Summary

Phase 3 randomized trial evaluating ultrasound-assisted thrombolysis with systemic tissue plasminogen activator for emergent revascularization in acute ischemic…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Drugs mentioned

• Activase (alteplase) (alteplase)

Snippet

Sponsor: Cerevast Therapeutics, Inc. | Conditions: Acute Ischemic Stroke | Phase 3 | Status: TERMINATED